Medinet Co
Leading CDMO in regenerative medicine and cell therapy, offering comprehensive solutions from research to commercial launch.
Market cap
$79.5m
Enterprise value
$44m
Share price
JPY38.00 2370.T
Recent deals
Authorizing premium user...
Leading CDMO in regenerative medicine and cell therapy, offering comprehensive solutions from research to commercial launch.